SPRINT trial – the beginning of marathon of changes in hypertension treatment? Review article
Article Sidebar
Main Article Content
Abstract
SPRINT is a crucial study concerning target blood pressure in patients with higher cardiovascular risk, also in elderly. It collates intensive treatment (systolic blood pressure reduction to circa 120 mmHg) with standard strategy (systolic blood pressure reduction below 140 mmHg). In the article the results of SPRINT are presented in reference to guidelines in hypertension treatment. The advantages and disadvantages of reduction of blood pressure below actually recommended values are discussed. The conclusions of recently published meta-analysis according to target blood pressure are also attached.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. Tykarski A., Narkiewicz K., Gaciong Z. et al.: 2015 Guidelines for the management of hypertension. Arterial Hypertens. 2015; 19(2): 53-83.
3. James P., Oparil S., Carter B. et al.: 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults. Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311(5): 507-520.
4. The SPRINT Research Group: A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N. Engl. J. Med. 2015; 373: 2103-2116.
5. The SPRINT Research Group: Supplement to: The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure. Online: http://www.nejm.org/doi/suppl/10.1056/NEJMoa1511939/suppl_file/nejmoa1511939_appendix.pdf (dostęp: 10.07.2016).
6. The SPRINT Research Group: The design and rationale of a multi-center clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT). Clin. Trials 2014; 11(5): 532-546.
7. Ettehad D., Emdin C.A., Kiran A. et al.: Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016; 387(10022): 957-967.
8. Xie X., Atkins E., Lv J. et al.: Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet 2016; 387(10017): 435-443.